Coronavirus is still claiming the lives of hundreds of Americans each week. According to official data released by the ...

High Paxlovid costs and prescribing barriers limit access for older adults and high-risk patients, despite continued free ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Despite available vaccines and treatments, COVID-19 continues to cause an average of 350 deaths weekly in the U.S., according ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. Image source: . Pfizer has a ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

CompanyOverview\|NYSE:PFE] A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income- ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Over 250 branded drugs saw price increases in the U.S., including Paxlovid and cancer therapies. 2. Median price hike was 4.5 ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have ...

The stock market staged a lightning-fast recovery, raising eyebrows and expectations. Dan Greenhaus emphasized that rapid rebounds often mirror the speed of previous declines, hinting at the market’s ...